姚記科技(002605.SZ):董事卞大雲減持期屆滿 擬繼續減持不超2.5萬股
格隆匯 12 月 29日丨姚記科技(002605.SZ)公佈,近日,公司收到公司董事、副總經理、董事會祕書卞大雲出具的《關於減持計劃期限屆滿的吿知函》和《關於股份減持計劃的吿知函》,截至公吿披露日,卞大雲前次預披露的減持計劃已期滿,並擬通過集中競價方式繼續減持公司股份。
截止公吿披露日,前述減持公司股份計劃期限已屆滿,在此減持計劃期間內,卞大雲未減持其持有的公司股份。
公司董事、副總經理、董事會祕書卞大雲計劃在自減持計劃公吿之日起15個交易日後的6個月內以集中競價的方式減持公司股份合計不超過2.5萬股(包含此數,佔公司目前總股本比例0.006%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.